Advanced search
Publication Cover
Rare Diseases Volume 4, 2016 - Issue 1
Journal homepage
2,251
Views
3
CrossRef citations to date
0
Altmetric
Addendum

Dystrophin: The dead calm of a dogma

Dariusz C. GóreckiMolecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UKCorrespondence[email protected]
Article: e1153777 | Received 24 Nov 2015, Accepted 04 Feb 2016, Published online: 23 Mar 2016

References

  • Dalkilic I, Kunkel LM. Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev 2003; 13: 231-8; PMID:12787784; http://dx.doi.org/10.1016/S0959-437X(03)00048-0
  • Yeung D, Zablocki K, Lien C-F, Jiang T, Arkle S, Brutkowski W, Brown J, Lochmuller H, Simon J, Barnard EA, Górecki DC. Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells. FASEB J 2006; 20(6): 610-20; PMID:16581969; http://dx.doi.org/10.1096/fj.05-4022com
  • Sinadinos A, Young C, AlKhalidi R, Teti A, Kalinski P, Mohamad S, Floriot L, Henry T, Tozzi G, Jiang T, et al. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of Duchenne muscular dystrophy. PLoS Med 2015 12(10): e1001888.
  • Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002; 11(3): 263-272; PMID:11823445; http://dx.doi.org/10.1093/hmg/11.3.263
  • Villalta SA, Rosenberg AS, Bluestone JA. The immune system in Duchenne muscular dystrophy: Friend or foe. Rare Dis 2015 Feb 23; 3(1):e1010966; http://dx.doi.org/10.1080/21675511.2015.1010966
  • Valladares D, Almarza G, Contreras A, Pavez M, Buvinic S, Jaimovich E, et al. Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy. PLoS One 2013; 8(11):e75340; PMID:24282497; http://dx.doi.org/10.1371/journal.pone.0075340
  • Idzko M, Ferrari D, Eltzschig HK. Nucleotide signalling during inflammation. Nature 2014; 509(7500): 310-317; PMID:24828189; http://dx.doi.org/10.1038/nature13085
  • Sandona D, Gastaldello S, Martinello T, Betto R. Characterization of the ATP-hydrolysing activity of alpha-sarcoglycan. Biochem J 2004; 381(1): 105-112; PMID:15032752; http://dx.doi.org/10.1042/BJ20031644
  • Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007; 28(9): 465-472; PMID:17692395; http://dx.doi.org/10.1016/j.tips.2007.07.002
  • Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272:735-8; PMID:8614837; http://dx.doi.org/10.1126/science.272.5262.735
  • Browne LE, Compan V, Bragg L, North RA. P2X7 receptor channels allow direct permeation of nanometer-sized dyes. J Neurosci 2013; 33:3557-66; PMID:23426683; http://dx.doi.org/10.1523/JNEUROSCI.2235-12.2013
  • North RA, Jarvis MF. P2X receptors as drug targets. Mol Pharmacol 2013; 83(4): 759-769; PMID:23253448; http://dx.doi.org/10.1124/mol.112.083758
  • Rawat R, Cohen TV, Ampong B, Francia D, Henriques-Pons A, Hoffman EP, et al. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol 2010; 176(6): 2891-2900; PMID:20413686; http://dx.doi.org/10.2353/ajpath.2010.090058
  • Gazzerro E, Baldassari S, Assereto S, Fruscione F, Pistorio A, Panicucci C, Volpi S, Perruzza L, Fiorillo C, Minetti C, et al. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis. Am J Pathol 2015; 185(12): 3349-60; PMID:26465071; http://dx.doi.org/10.1016/j.ajpath.2015.08.010
  • Giordano C, Mojumdar K, Liang F, Lemaire C, Li T, Richardson J, et al. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Hum Mol Genet 2014; 24(8): 2147-2162; PMID:25552658; http://dx.doi.org/10.1093/hmg/ddu735
  • Young C, Brutkowski W, Lien C-F, Arkle S, Lochmüller H, Zabłocki K and Górecki DC. P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: Relationship to pathology and potential target for treatment.” J Cell Mol Med 2012; 16(5):1026-37; PMID:21794079; http://dx.doi.org/10.1111/j.1582-4934.2011.01397.x
  • Young C, Sinadinos A, Lefebvre A, Chan P, Arkle S, Vaudry D and Górecki DC. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large pore formation and HSP90. Autophagy 2015; 11(1):113-30; PMID:25700737; http://dx.doi.org/10.4161/15548627.2014.994402
  • Ferrari D, Munerati M, Melchiorri L, Hanau S, di Virgilio F, Baricordi OR. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients. Am J Physiol 1994; 267(4 Pt 1): C886-892; PMID:7524344
  • Jasmin G, Tautu C, Vanasse M, Brochu P, Simoneau R. Impaired muscle differentiation in explant cultures of Duchenne muscular dystrophy. Lab Invest 1984; 50:197-207; PMID:6694359
  • Lucas-Heron B, Mussini JM, Ollivier B. Is there a maturation defect related to calcium in muscle mitochondria from dystrophic mice and Duchenne and Becker muscular dystrophy patients. J Neurol Sci 1989; 90: 299-306; PMID:2738610; http://dx.doi.org/10.1016/0022-510X(89)90116-0
  • Yablonka-Reuveni Z, Anderson JE. Satellite cells from dystrophic (mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers. Dev Dyn 2006; 235(1): 203-212; PMID:16258933; http://dx.doi.org/10.1002/dvdy.20602
  • Onopiuk M, Brutkowski W, Wierzbicka K, Wojciechowska S, Szczepanowska J, Fronk J, Lochmüller H, Górecki DC, Zabłocki K. Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts. Biochem Biophys Res Com 2009; 386(3): 463-466; http://dx.doi.org/10.1016/j.bbrc.2009.06.053
  • Onopiuk M, Brutkowski W, Young CNJ, Krasowska E, Róg J, Ritso M, Wojciechowska S, Arkle S, Zabłocki K, Górecki DC. Store-operated calcium entry contributes to abnormal Ca2+ signalling in dystrophic mdx mouse myoblasts. Archives Biochem. Biophys 2015; 569:1-9
  • Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010; 143(7):1059-71; PMID:21145579; http://dx.doi.org/10.1016/j.cell.2010.11.039
  • Mourkioti F, Kustan J, Kraft P, Day JW, Zhao MM, Kost-Alimova M, Protopopov A, DePinho RA, Bernstein D, Meeker AK, Blau HM. Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. Nat Cell Biol 2013; 15(8):895-904; PMID:23831727; http://dx.doi.org/10.1038/ncb2790
  • Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, Rudnicki MA. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 2015 Nov 16; 21(12):1455-63; [ Epub ahead ofprint].
  • Ghahramani Seno MM, Graham IR, Athanasopoulos T, Trollet C, Pohlschmidt M, Crompton MR, Dickson G. RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology. Hum Mol Genet 2008; 17(17):2622-32; PMID:18511456; http://dx.doi.org/10.1093/hmg/ddn162
  • Merrick D, Stadler LK, Larner D, Smith J. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis Model Mech 2009; 2(7-8):374-88; PMID:19535499; http://dx.doi.org/10.1242/dmm.001008
  • Górecki DC, Monaco AP, Derry JM, Walker AP, Barnard EA, Barnard PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1992; 1(7): 505-510; PMID:Can't; http://dx.doi.org/10.1093/hmg/1.7.505
  • Snow WM, Anderson JE, Jakobson LS. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav Rev 2013;37(5): 743-752; PMID:23545331; http://dx.doi.org/10.1016/j.neubiorev.2013.03.016
  • Krasowska E, Zabłocki K, Górecki DC, Swinny JD. Aberrant location of inhibitory synaptic marker proteins in the hippocampus of dystrophin-deficient mice: implications for cognitive impairment in Duchenne muscular dystrophy. In: PLoS One 2014; 9: 9, p. e108364; PMID:25260053; http://dx.doi.org/10.1371/journal.pone.0108364
  • Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, Lee JC, Henze J, Fletcher BS, Gu Z, et al. Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nat Genet 2014; 46(6):601-6; PMID:24793134; http://dx.doi.org/10.1038/ng.2974
  • Tennyson CN, Klamut HJ, Worton RG. “The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced”. Nat Genet 1995; 9 (2): 184-90; PMID:7719347; http://dx.doi.org/10.1038/ng0295-184
  • Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet 1993; 3: 283-291; PMID:7981747; http://dx.doi.org/10.1038/ng0493-283
  • Bovolenta M, Erriquez D, Valli E, Brioschi S, Scotton C, Neri M, Falzarano MS, Gherardi S, Fabris M, Rimessi P, et al. The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoforms. PLoS One 2012; 7(9):e45328; PMID:23028937; http://dx.doi.org/10.1371/journal.pone.0045328
  • Neguembor MV, Jothi M, Gabellini D. Long noncoding RNAs, emerging players in muscle differentiation and disease. Skeletal Muscle 2014; 4(1):8; PMID:24685002; http://dx.doi.org/10.1186/2044-5040-4-8
  • Twayana S, Legnini I, Cesana M, Cacchiarelli D, Morlando M, Bozzoni I. Biogenesis and function of non-coding RNAs in muscle differentiation and in Duchenne muscular dystrophy. Biochem Soc Trans 2013; 41(4):844-9; PMID:23863142; http://dx.doi.org/10.1042/BST20120353
  • Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147(2):358-69; PMID:22000014; http://dx.doi.org/10.1016/j.cell.2011.09.028
  • Percival JM, Whitehead NP, Adams ME, Adamo CM, Beavo JA, Froehner SC. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol 2012; 228(1): 77-87; PMID:22653783
  • Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, et al. "Hsp72 preserves muscle function and slows progression of severe muscular dystrophy”. Nature 2012; 484(7394):394-8; PMID:22495301; http://dx.doi.org/10.1038/nature10980
  • Vieira NM, Elvers I, Alexander MS, Moreira YB, Eran A, Gomes JP, Marshall JL, Karlsson EK, Verjovski-Almeida S, Lindblad-Toh K, et al. Jagged 1 rescues the duchenne muscular dystrophy phenotype. Cell 2015 Nov 11; 163(5):1204-13; pii: S0092-8674(15)01405-1. [Epub ahead of print].
  • Allen DG, Whitehead NP, Froehner SC. Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. Physiol Rev 2016; 96(1): 253-305; PMID:26676145; http://dx.doi.org/10.1152/physrev.00007.2015
  • van Putten M, Hulsker M, Nadarajah VD, van Heiningen SH, van Huizen E, van Iterson M, Admiraal P, Messemaker T, den Dunnen JT, 't Hoen PA, et al. The effects of low levels of dystrophin on mouse muscle function and pathology. PLoS One 2012; 7(2):e31937; PMID:22359642; http://dx.doi.org/10.1371/journal.pone.0031937

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.